Adhoc: Sandoz Group AG: Sandoz launches new semaglutide treatment option in Brazil, expanding patient access to GLP-1 medicine in key global market

Sandoz Group AG / Key word(s): Market Launch Sandoz launches new semaglutide treatment option in Brazil, expanding patient access to GLP-1 medicine in key global market 09-Nov-2026 / 07:00 CET/CES…

Weiterlesen auf der Quellseite

Ähnliche Beiträge